7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Rupture, Spontaneous D012422 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Hyperostosis D015576 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kostenuik PJ et al. OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats. 2001 Endocrinology pmid:11564687
Seidel C et al. Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. 2001 Blood pmid:11568016
Yan T et al. Regulation of osteoclastogenesis and RANK expression by TGF-beta1. 2001 Aug 1-9 J. Cell. Biochem. pmid:11573248
Fukagawa M et al. Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases. 2001 Am. J. Kidney Dis. pmid:11576943
Sato T et al. Osteoprotegerin levels before and after renal transplantation. 2001 Am. J. Kidney Dis. pmid:11576949
Feuerherm AJ et al. Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. 2001 Scand. J. Rheumatol. pmid:11578019
Quinn JM et al. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. 2001 J. Bone Miner. Res. pmid:11585342
Choi SJ et al. Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment. 2001 J. Bone Miner. Res. pmid:11585344
Miyamoto T et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. 2001 Blood pmid:11588053
Satoh K et al. Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer. 2001 Pancreas pmid:11590320
Yano K et al. Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy. 2001 Biochem. Biophys. Res. Commun. pmid:11594776
Brown JM et al. Serum osteoprotegerin levels are increased in patients with advanced prostate cancer. 2001 Clin. Cancer Res. pmid:11595685
Price PA et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11597934
Rosa-Rañal M et al. [New paradigms in the regulation of bone metabolism]. 2001 Jul-Aug Rev. Invest. Clin. pmid:11599485
Kawahara N et al. Two novel cucurbitacins, neocucurbitacins A and B, from the Brazilian folk medicine "Buchinha" (Luffa operculata) and their effect on PEBP2alphaA and OCIF gene expression in a human osteoblast-like Saos-2 cell line. 2001 Chem. Pharm. Bull. pmid:11605678
Boissy P et al. RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons. 2001 Biochem. Biophys. Res. Commun. pmid:11606048
Jung K et al. Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer. 2001 Clin. Chem. pmid:11673385
Lean JM et al. FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function. 2001 Blood pmid:11675341
Fiumara P et al. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. 2001 Blood pmid:11675352
Yano K et al. Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor. 2001 J. Bone Miner. Metab. pmid:11685652

Table of Content